Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Northwell Health
M.D. Anderson Cancer Center
University Hospitals Bristol and Weston NHS Foundation Trust
Brigham and Women's Hospital
Institute of Cancer Research, United Kingdom
Institut Cancerologie de l'Ouest
NRG Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jonsson Comprehensive Cancer Center
University of Washington
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Southern California
Institut Bergonié
University of Washington
Memorial Sloan Kettering Cancer Center
University of Chicago
University of Kansas Medical Center
Hoosier Cancer Research Network
Columbia University
Emory University
UNC Lineberger Comprehensive Cancer Center
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Stanford University
University of Pennsylvania
University of Utah
Indiana University
PrECOG, LLC.
Southern Illinois University
Roswell Park Cancer Institute
Hoosier Cancer Research Network
Northwestern University
M.D. Anderson Cancer Center
Cedars-Sinai Medical Center
The University of Texas Health Science Center at San Antonio
University of Oklahoma
University of Texas Southwestern Medical Center
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey
SCRI Development Innovations, LLC
Hoosier Cancer Research Network
University of California, Irvine
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Corewell Health West
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
Mayo Clinic